Otros idiomas Champions Oncology, Inc.

Acciones

CSBR

US15870P3073

Mercado cerrado - Nasdaq Otros sitios de cotización 22:30:00 06/05/2024			Varia. Cinco días.	Varia. 1 de enero.
4,9 ^USD	-4,48 %		-0,41 %	-12,81 %

13/03	CHAMPIONS ONCOLOGY, INC. : Craig-Hallum da una recomendación neutral	ZM
12/03	Champions Oncology, Inc. informa de los resultados del tercer trimestre y de los nueve meses finalizados el 31 de enero de 2024	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.	15/03
Champions Oncology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	12/03
Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation	08/03
Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.	13/12
Champions Oncology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	12/12
MORNING BID AMERICAS-Disinflation station	12/12
North American Morning Briefing : Traders Eye -2-	12/12
Champions Oncology, Inc: Champions Oncology erhält für seinen europäischen Forschungsstandort eine ISO-9001:2015-Akkreditierung und ATS-Zertifizierung	02/11
Champions Oncology, Inc.	02/11
Champions Oncology Announces the Addition of Brady Davis as President	18/10/23
Champions Oncology, Inc. Appoints Brady Davis as President	17/10/23
Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.	13/09/23
Champions Oncology : Reports Quarterly Revenue of $12.6 Million - Form 8-K	13/09/23
Champions Oncology, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2023	13/09/23
Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies	02/08/23
Champions Oncology Enters Multiyear Deal With BioVolume to Better Evaluate Cancer Studies	01/08/23
Champions Oncology, Inc. Announces Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies	01/08/23
Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.	24/07/23
Champions Oncology, Inc. Reports Earnings Results for the Full Year Ended April 30, 2023	24/07/23
Champions Oncology, Inc. Reports Earnings Results for the Fourth Quarter Ended April 30, 2023	24/07/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Champions Oncology, Inc.

Acciones

CSBR

US15870P3073

Otros idiomas

Filtros